Newbury Park, CA, United States of America

Anne Navratil

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Amgen Inc.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anne Navratil. Retrieved from https://idiyas.com/inventor/anne-navratil

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Anne Navratil

Introduction

Anne Navratil is a notable inventor based in Newbury Park, California. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stable emulsion formulations. Her work focuses on improving the safety and efficacy of injectable medications.

Latest Patents

Anne Navratil holds 1 patent for her invention titled "Stable emulsion formulations." This patent relates to injectable formulations of irritant agents, such as calcimimetics, that are pharmaceutically stable. The formulations demonstrate a reduced incidence of irritation, pain, phlebitis, precipitation, and hemolysis upon injection, which is crucial for patient comfort and safety.

Career Highlights

Anne Navratil is currently employed at Amgen Inc., a leading biotechnology company known for its innovative therapies. Her role at Amgen allows her to contribute to the development of groundbreaking treatments that improve patient outcomes.

Collaborations

Throughout her career, Anne has collaborated with talented professionals, including Anuradha V Gore and Seshadri Neervannan. These collaborations have enhanced her research and development efforts, leading to advancements in pharmaceutical formulations.

Conclusion

Anne Navratil's work exemplifies the impact of innovation in the pharmaceutical industry. Her contributions to stable emulsion formulations are paving the way for safer and more effective injectable therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…